摘要 |
<p>1445871 2-Deoxy-streptamine-aminoglycosides PFIZER Ltd 4 June 1974 [5 June 1973] 26718/73 Divided out of 1445872 Heading C2C Novel compounds II in which R<SP>1</SP> is H or Me, R<SP>2</SP>' is optionally protected hydroxy or NHR<SP>4</SP>, R<SP>3</SP>' is H or optionally protected hydroxy, R<SP>4</SP> is a monovalent protecting group for a primary amino group, R<SP>6</SP> is optionally protected hydroxyl or OR<SP>5'</SP> (in which R<SP>5</SP>' is a hexapyranosyl group containing two or more optionally protected hydroxy radicals and optionally containing an NHR 4 or NHMe group) R<SP>7</SP> is optionally protected hydroxyl and the dotted line represents an optional bond when R<SP>3</SP>' is H; are prepared from compounds V in which R<SP>2</SP> is H 2 N or OH, R<SP>3</SP> is H or NH 2 and R<SP>5</SP> is H or R<SP>6</SP>' by protecting all primary amino groups with R<SP>4</SP> and, if desired, protecting any free hydroxyl groups and selectively deprotecting the 6<SP>1</SP>-amino group by controlled soloolysis. Compounds II are also prepared by selectively protecting the 61-amino group of a compound V with benzyloxycarbonyl, protecting the remaining primary amino groups with R<SP>4</SP> (other than benzyloxycarbonyl) and, if necessary, protecting some or all of the free hydroxyl groups present and selectively removing the 6<SP>1</SP>-N- benzyloxycarbonyl group. Methoxycarbonyl and t-butyloxycarbonyl protected derivatives of neamine, kanamycin A and kanamycin B are prepared.</p> |